1. Home
  2. LASR vs INDV Comparison

LASR vs INDV Comparison

Compare LASR & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nLIGHT Inc.

LASR

nLIGHT Inc.

HOLD

Current Price

$39.53

Market Cap

4.1B

Sector

Technology

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$36.80

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASR
INDV
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.7B
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
LASR
INDV
Price
$39.53
$36.80
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
★ $54.31
N/A
AVG Volume (30 Days)
982.8K
★ 1.4M
Earning Date
05-07-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
62.99
★ 8100.00
EPS
N/A
★ 1.67
Revenue
$191,359,000.00
★ $1,239,000,000.00
Revenue This Year
$10.91
N/A
Revenue Next Year
$14.32
N/A
P/E Ratio
★ N/A
$22.08
Revenue Growth
★ 38.09
4.29
52 Week Low
$28.05
$22.56
52 Week High
$86.95
$42.81

Technical Indicators

Market Signals
Indicator
LASR
INDV
Relative Strength Index (RSI) 37.92 57.99
Support Level $38.95 $35.78
Resistance Level $40.00 $38.12
Average True Range (ATR) 1.48 0.93
MACD 0.86 0.36
Stochastic Oscillator 44.25 97.83

Price Performance

Historical Comparison
LASR
INDV

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products segment, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA, of which maximum revenue is derived from North America.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: